The Hidden Supply Chain Risk in Your Nonwovens Sourcing Strategy

Procurement teams increasingly ask detailed questions about product origin. After years of shifting procurement overseas in pursuit of lower prices, healthcare systems have learned the risks of depending on global supply chains susceptible to production and shipping interruptions.² Choosing a domestic or near-shore nonwovens manufacturer in the Americas, rather than an overseas supplier, can result in shorter lead times, fewer logistical variables, and greater production transparency. The benefits of domestic sourcing include decreasing product shipping time, providing clarity into the supply chain, and meeting federal and local requirements for domestic sourcing. ²

For medical and surgical fabric applications, these concerns are tangible. Fabric delays can disrupt production schedules and potentially impact patient care.

Many nonwoven fabric suppliers claim reliability, but fewer can demonstrate it. Vertical integration — controlling the manufacturing process from raw materials to finished goods — is a strong indicator of supply chain resilience. It reduces external dependencies, improves quality control at every stage, and increases flexibility to respond to changing demand. The scale of overseas dependency in medical supply makes this especially relevant: nearly 70% of medical devices marketed in the U.S. are manufactured exclusively overseas, ³ creating potential exposure to logistics disruption, extended lead times, and sourcing uncertainty that vertically integrated domestic manufacturers are often better positioned to absorb.

ISO 13485 establishes a framework to ensure the consistent design, development, production, and delivery of medical devices that are safe for their intended purpose, helping meet thorough regulatory requirements and manage risk at every stage of the supply chain. ⁴ For those sourcing nonwoven fabric for medical or surgical applications, this certification should be a baseline requirement. It indicates that a supplier maintains documented processes, oversight, and quality controls to consistently meet tight regulatory standards.

This matters more today than ever before. As of February 2, 2026, the FDA’s new Quality Management System Regulation (QMSR) came into force, formally incorporating ISO 13485:2016 by reference into 21 CFR Part 820, making conformance to this standard a U.S. federal regulatory requirement rather than simply an industry best practice.⁵ For procurement leaders evaluating nonwovens suppliers for medical applications, ISO 13485 certification is no longer only a quality signal. It is a direct indicator of a supplier’s readiness to meet current federal manufacturing standards.

Standard products may suffice initially, but specific requirements arise more often than buyers anticipate. The ability to customize basis weights, colors, treatment packages, and laminate composite fabric constructions is essential for medical and surgical applications where performance specifications are non-negotiable. A supplier offering spunbond, meltblown, SMS, and laminate composite options across a range of configurations gives you flexibility as your product requirements evolve. That range of capabilities can distinguish a long-term manufacturing partner from a transactional supplier you may eventually outgrow.

The COVID-19 pandemic exposed the vulnerabilities of just-in-time inventory models — supply chains that had performed well in stable conditions faced unprecedented challenges under pressure. ⁶ That lesson has reshaped how procurement leaders think about supplier selection. A domestic nonwovens manufacturer with substantial warehousing capacity can provide a protective buffer when demand spikes. It is worth addressing this factor directly with any supplier you are evaluating.

HALYARD* has manufactured nonwoven fabrics in the Americas for over 40 years. Our Lexington, NC facility produces spunbond, meltblown, SMS, and customized laminate composite fabrics in various colors, basis weights, and treatment packages for medical, surgical, hygiene, filtration, wipes, and industrial applications.

As part of the Owens & Minor family of brands, a global healthcare solutions company with more than 140 years of supply chain expertise, HALYARD* nonwovens are backed by one of the most established and vertically integrated supply networks in the industry. We are ISO 13485 certified and maintain substantial warehousing capacity. With over four decades of experience as a nonwoven fabric supplier for medical applications, we have successfully navigated numerous supply chain challenges and remain committed to delivering when it matters most.

If you are evaluating your nonwovens supplier strategy, we welcome the opportunity to discuss how we can support your needs.

Simply fill out the form below and we’ll be in touch with you shortly.